Griffithsin, a Highly Potent Broad-Spectrum Antiviral Lectin from Red Algae: From Discovery to Clinical Application
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Virus entry into a susceptible host cell is the first step in the formation of all viral diseases. Controlling viral infections by disrupting viral entry is advantageous for antibody-mediated neutralization by the host’s immune system and as a preventive and therapeutic antiviral strategy. Recently, several plant-derived carbohydrate-binding proteins (lectins) have emerged as a new class of antiviral biologics by taking advantage of a unique glycosylation pattern only found on the surface of viruses. In particular, a red algae-derived griffithsin (GRFT) protein has demonstrated superior in vitro and in vivo antiviral activity with minimum host toxicity against a variety of clinically relevant, enveloped viruses. This review examines the structural characteristics of GRFT, focusing on its carbohydrate-binding capability. Its in vitro antiviral profiles against human immunodeficiency virus (HIV) are also discussed followed by a description of the results from a combination study using anti-HIV drugs. The results of several studies regarding its novel antiviral mechanism of action are provided in conjunction with an explanation of viral resistance profiles to GRFT. In addition, its in vitro and in vivo host toxicity profiles are summarized with its pharmacokinetic behavior using in vivo efficacy study results. Also, a large-scale production and formulation strategy, as well as a drug delivery strategy, for GRFT as a new class of broad-spectrum microbicides is discussed. Finally, results from two ongoing clinical studies examining GRFT’s effects on viruses are presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The amino acid sequence of griffithsin (GRFT). Corresponding secondary β-sheet structures are marked with yellow arrows based on the crystal structure of a GRFT dimer with mannose at a resolution of 1.78 Å [19]. Tyrosine and aspartate residues in three carbohydrate-binding domains, which are essential for mannose-binding, are noted with blue and orange arrows, respectively. Wild-type GRFT has a non-standard amino acid at position 31, but it is replaced by alanine (colored in red) in recombinant GRFT. The sequence display was generated by the RCSB protein data bank website (www.rcsb.org).](https://figures.cochat.ai/paper-figures/1fd42505c6ef428985401d5005e46d4b/griffithsin-a-highly-potent-broad-spectrum-antiviral-lectin-from-red-algae-from-figure-1.jpg)
![Figure 2 The crystal structure of a GRFT dimer with six mannoses at a resolution of 1.78 Å [19]. Each GRFT monomer is presented in either red or blue. Six bound mannose molecules are shown with ball and stick models. This image was created with PDB ID and associated publication, NGL Viewer (AS Rose et al. (2018) NGL viewer: web-based molecular graphics for large complexes. Bioinformatics doi:10.1093/bioinformatics/bty419), and RCSB PDB.](https://figures.cochat.ai/paper-figures/bc6833ca02e5443ca2b5789603c52e60/griffithsin-a-highly-potent-broad-spectrum-antiviral-lectin-from-red-algae-from-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some cyanobacteria and microalgae contain specific compounds which have been shown to have potent antiviral properties.”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Lee, 2019
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This includes red algae lectins such as griffithsin from marine Griffithsia sp. (Lee, 2019) and cyanobacterial lectins such as Cyanovirin-N from freshwater Nostoc ellipsosporum (Lotfi et al., 2018).”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Lee, 2019
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Global epidemiology of HIV infection in men who have sex with men
Beyrer, C., Baral, S. D., van Griensven, F., Goodreau, S. M., Chariyalertsak, S., Wirtz, A. L., & Brookmeyer, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60821-6 · Cited by 1,559
Mori, T., O'Keefe, B. R., Sowder, R. C., Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J. A., Buckheit, R. W., McMahon, J. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411122200 · Cited by 445
O'Keefe, B. R., Giomarelli, B., Barnard, D. L., Shenoy, S. R., Chan, P. K. S., McMahon, J. B., Palmer, K. E., Barnett, B. W., Meyerholz, D. K., Wohlford-Lenane, C. L., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02322-09 · Cited by 303
O'Keefe, B. R., Vojdani, F., Buffa, V., Shattock, R. J., Montefiori, D. C., Bakke, J., Mirsalis, J., d'Andrea, A.-L., Hume, S. D., Bratcher, B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901506106 · Cited by 262
A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication
Swanson, M. D., Winter, H. C., Goldstein, I. J., & Markovitz, D. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.034926 · Cited by 214
Toxicity of antiretroviral therapy and implications for drug development
Carr, A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1151 · Cited by 191
Potent Anti-Influenza Activity of Cyanovirin-N and Interactions with Viral Hemagglutinin
O'Keefe, B. R., Smee, D. F., Turpin, J. A., Saucedo, C. J., Gustafson, K. R., Mori, T., Blakeslee, D., Buckheit, R., & Boyd, M. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2518-2525.2003 · Cited by 188
Ziółkowska, N. E., O'Keefe, B. R., Mori, T., Zhu, C., Giomarelli, B., Vojdani, F., Palmer, K. E., McMahon, J. B., & Wlodawer, A. (2006) · Structure · doi:10.1016/j.str.2006.05.017 · Cited by 172
Griffithsin: An Antiviral Lectin with Outstanding Therapeutic Potential
Lusvarghi, S., & Bewley, C. A. (2016) · Viruses · doi:10.3390/v8100296 · Cited by 164
Cited by
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.044 · Cited by 1,016
Michalak, I., Tiwari, R., Dhawan, M. K., Alagawany, M. M., Farag, M. R., Sharun, K., Emran, T. B., & Dhama, K. (2022) · Veterinary Quarterly · doi:10.1080/01652176.2022.2061744 · Cited by 173
Pereira, L., & Critchley, A. T. (2020) · Journal of Applied Phycology · doi:10.1007/s10811-020-02143-y · Cited by 115
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Almehdi, A. M., Khoder, G., Alchakee, A., Alsayyid, A. T., Sarg, N. H., & Soliman, S. S. M. (2021) · Infection · doi:10.1007/s15010-021-01677-8 · Cited by 123
Unlocking the potential of marine biodiscovery
Sigwart, J. D., Blasiak, R., Jaspars, M., Jouffray, J., & Taşdemir, D. (2021) · Natural Product Reports · doi:10.1039/d0np00067a · Cited by 123
Pharmacokinetics of Marine-Derived Drugs
Shikov, A. N., Флисюк, Е. В., Obluchinskaya, E. D., & Pozharitskaya, O. N. (2020) · Marine Drugs · doi:10.3390/md18110557 · Cited by 106
Pang, Y., Yao, L., Jhong, J.-H., Wang, Z., & Lee, T.-Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab263 · Cited by 103
Cyanobacteria and microalgae in supporting human habitation on Mars
Mapstone, L. J., Leite, M. N., Purton, S., Crawford, I. A., & Dartnell, L. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2022.107946 · Cited by 92
“This includes red algae lectins such as griffithsin from marine Griffithsia sp. (Lee, 2019) and cyanobacterial lectins such as Cyanovirin-N from freshwater Nostoc ellipsosporum (Lotfi et al., 2018).”
Microalgal Bioeconomy: A Green Economy Approach Towards Achieving Sustainable Development Goals
Sarker, N. K., & Kaparaju, P. (2024) · Sustainability · doi:10.3390/su162411218 · Cited by 74
Natural product-derived compounds in clinical trials and drug approvals
Butler, M. S., Capon, R. J., Blaskovich, M. A. T., & Henderson, I. R. (2026) · Natural Product Reports · doi:10.1039/d5np00031a · Cited by 98
Reynolds, D., Huesemann, M. H., Edmundson, S. J., Sims, A. M., Hurst, B. L., Cady, S. L., Beirne, N., Freeman, J., Berger, A., & Gao, S. (2021) · Algal Research · doi:10.1016/j.algal.2021.102331 · Cited by 82
Therapeutic activity of fucoidan and carrageenan as marine algal polysaccharides against viruses
Oliyaei, N., Moosavi‐Nasab, M., & Mazloomi, S. M. (2022) · 3 Biotech · doi:10.1007/s13205-022-03210-6 · Cited by 83
Algae-derived bioactive molecules for the potential treatment of SARS-CoV-2
Alam, M. A., Parra-Saldivar, R., Bilal, M., Afroze, C. A., Ahmed, M. N., Iqbal, H. M. N., & Xu, J. (2021) · Molecules · doi:10.3390/molecules26082134 · Cited by 69
“Therefore, Griffithsin may be effective against SARS-CoV-2 because it can inhibit virus entry, reverse transcriptase activity, integrase activity, and protease activity [40].”
Backgroundda Silva, L. C. N., Mendonça, J. S. P., de Oliveira, W. F., Batista, K. L. R., Zagmignan, A., Viana, I. F. T., & Correia, M. T. D. S. (2020) · Glycobiology · doi:10.1093/glycob/cwaa099 · Cited by 73
Ten-Year Research Update Review: Antiviral Activities from Marine Organisms
Riccio, G., Ruocco, N., Mutalipassi, M., Costantini, M., Zupo, V., Coppola, D., de Pascale, D., & Lauritano, C. (2020) · Biomolecules · doi:10.3390/biom10071007 · Cited by 74
Natural Products with Potential to Treat RNA Virus Pathogens Including SARS-CoV-2
Christy, M. P., Uekusa, Y., Gerwick, L. G., & Gerwick, W. H. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00968 · Cited by 67
Cai, Y., Xu, W., Gu, C., Cai, X., Qu, D., Lu, L., Xie, Y., & Jiang, S. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00305-3 · Cited by 65
Saied, E. M., El‐Maradny, Y. A., Osman, A. A., Darwish, A. M. G., Nahas, H. H. A., Niedbała, G., Piekutowska, M., Abdel-Rahman, M. A., Balbool, B. A., & Abdel-Azeem, A. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111759 · Cited by 65
Antiviral Potential of Algal Metabolites—A Comprehensive Review
Pagarete, A., Ramos, A. S., Puntervoll, P., Allen, M. J., & Verdelho, V. (2021) · Marine Drugs · doi:10.3390/md19020094 · Cited by 61
Lectins and lectibodies: potential promising antiviral agents
Nabi‐Afjadi, M., Heydari, M., Zalpoor, H., Arman, İ., Sadoughi, A., Sahami, P., & Aghazadeh, S. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00338-4 · Cited by 65
The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options
Asghari, A., Naseri, M., Safari, H., Saboory, E., & Parsamanesh, N. (2020) · DNA and Cell Biology · doi:10.1089/dna.2020.5703 · Cited by 63
Microalgal drugs: A promising therapeutic reserve for the future
Ahirwar, A., Kesharwani, K., Deka, R., Muthukumar, S., Khan, M. J., Rai, A., Vinayak, V., Varjani, S., Joshi, K. B., & Morjaria, S. (2022) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2022.03.012 · Cited by 55
The antiviral potential of algal-derived macromolecules
Liu, J., Obaidi, I., Nagar, S., Scalabrino, G., & Sheridan, H. (2021) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2021.04.003 · Cited by 59
Sukmarini, L. (2022) · Molecules · doi:10.3390/molecules27092619 · Cited by 53
Dube, T., Ghosh, A., Mishra, J., Kompella, U. B., & Panda, J. J. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000172 · Cited by 52
Wang, W., Li, Q., Wu, J., Hu, Y., Wu, G., Yu, C., Xu, K., Liu, X., Wang, Q., Huang, W., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1957720 · Cited by 55
Alsaidi, S., Cornejal, N., Mahoney, O., Melo, C., Verma, N., Bonnaire, T., Chang, T. L.-Y., O’Keefe, B. R., Sailer, J., Zydowsky, T. M., et al. (2021) · Marine Drugs · doi:10.3390/md19080418 · Cited by 47
Remarkable Natural Biological Resource of Algae for Medical Applications
Dai, N., Wang, Q., Xu, B., & Chen, H. (2022) · Frontiers in Marine Science · doi:10.3389/fmars.2022.912924 · Cited by 51
Kar, J., Ramrao, D. P., Zomuansangi, R., Lalbiaktluangi, C., Singh, S. M., Joshi, N. C., Kumar, A., Kaushalendra, K., Mehta, S., Yadav, M. K., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1034471 · Cited by 50
Hwang, H., Han, J.-W., Jeon, H., Cho, K., Kim, J., Lee, D.-S., & Han, J. W. (2020) · Biomolecules · doi:10.3390/biom10020333 · Cited by 45
Yan, S., Sun, H., Bu, X., & Wan, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00912 · Cited by 44
Llivisaca-Contreras, S. A., Naranjo-Morán, J., Pino-Acosta, A., Pieters, L. A. C., Berghe, W. V., Manzano, P., Pérez, J. V., León-Tamaríz, F., & Cevallos‐Cevallos, J. M. (2021) · Molecules · doi:10.3390/molecules26134099 · Cited by 44
Khaligh, S. F., & Asoodeh, A. (2022) · 3 Biotech · doi:10.1007/s13205-022-03327-8 · Cited by 44
Existing Antiviral Options Against SARS-CoV-2 Replication in COVID-19 Patients
Ghanbari, R., Teimoori, A., Sadeghı, A., Mohamadkhani, A., Rezasoltani, S., Asadi, E., Jouyban, A., & Sumner, S. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0120 · Cited by 44
Plant-Derived Antimicrobial Peptides as Potential Antiviral Agents in Systemic Viral Infections
Mammari, N., Krier, Y., Albert, Q., Devocelle, M. C., Varbanov, M., & OEMONOM, O. B. O. T. (2021) · Pharmaceuticals · doi:10.3390/ph14080774 · Cited by 41
Tan, F. H., Sukri, A., Idris, N., Ong, K. C., Schee, J. P., Tan, C. T., Tan, S. H., Wong, K. T., Wong, L. P., Tee, K. K., et al. (2024) · Virus Evolution · doi:10.1093/ve/veae048 · Cited by 49
Jain, S., Khaiboullina, S. F., & Baranwal, M. (2020) · Pathogens · doi:10.3390/pathogens9100850 · Cited by 38
The direct and indirect effects of bioactive compounds against coronavirus
Tomaş, M., Çapanoğlu, E., Bahrami, A., Hosseini, H., Akbari‐Alavijeh, S., Shaddel, R., Rehman, A., Rezaei, A., Rashidinejad, A., Garavand, F., et al. (2021) · Food Frontiers · doi:10.1002/fft2.119 · Cited by 39
Microalgae-Derived Peptides: Exploring Bioactivities and Functional Food Innovations
Ashraf, A., Guo, Y., Yang, T., ud Din, A. S., Ahmad, K., Li, W., & Hou, H. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c06800 · Cited by 32
Alavi, M., Asare‐Addo, K., & Nokhodchi, A. (2020) · Biomedicines · doi:10.3390/biomedicines8120580 · Cited by 34
Viral infections in cultured fish and shrimps: current status and treatment methods
Mondal, H., Chandrasekaran, N., Mukherjee, A., & Thomas, J. (2021) · Aquaculture International · doi:10.1007/s10499-021-00795-2 · Cited by 33
Coronaviruses and Nature’s Pharmacy for the Relief of Coronavirus Disease 2019
Chinsembu, K. C. (2020) · Revista Brasileira de Farmacognosia · doi:10.1007/s43450-020-00104-7 · Cited by 31
Kalasariya, H. S., Patel, N. B., Gacem, A., Alsufyani, T. A., Reece, L. M., Yadav, V. K., Awwad, N. S., Ibrahium, H. A., Ahn, Y., Yadav, K. K., et al. (2022) · Marine Drugs · doi:10.3390/md20090586 · Cited by 29
Maliki, I. M., Misson, M., Teoh, P. L., Rodrigues, K. F., & Yong, W. T. L. (2022) · Marine Drugs · doi:10.3390/md20020102 · Cited by 28
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
England, C., TrejoMartinez, J., PerezSanchez, P., Karki, U., & Xu, J. (2023) · Life · doi:10.3390/life13030617 · Cited by 27
Antimicrobial peptides for novel antiviral strategies in the current post‐COVID‐19 pandemic
Loffredo, M. R., Nencioni, L., Mangoni, M. L., & Casciaro, B. (2023) · Journal of Peptide Science · doi:10.1002/psc.3534 · Cited by 25
Antitumor lectins from algae: A systematic review
de Arruda, M. C. S., da Silva, M. R. O. B., Cavalcanti, V. L. R., Brandão, R., Marques, D. D. A. V., de Lima, L. R. A., Porto, A. L. F., & Bezerra, R. P. (2023) · Algal Research · doi:10.1016/j.algal.2022.102962 · Cited by 24
Algal and Cyanobacterial Lectins and Their Antimicrobial Properties
Fernández Romero, J. A., Paglini, M. G., Priano, C., Koroch, A., Rodríguez, Y., Sailer, J., & Teleshova, N. (2021) · Marine Drugs · doi:10.3390/md19120687 · Cited by 21
Cai, Y., Xu, W., Tang, J., Cao, N., Lan, Q., Lu, L., & Jiang, S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00638-w · Cited by 21
In vitro Inhibition of HIV-1 by Cyclotide-Enriched Extracts of Viola tricolor
Conzelmann, C., Muratspahić, E., Tomašević, N., Münch, J., & Gruber, C. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.888961 · Cited by 22
Chukwudulue, U. M., Barger, N., Dubovis, M., & Luzzatto‐Knaan, T. (2023) · Marine Drugs · doi:10.3390/md21110569 · Cited by 20
Algal Metabolites Can Be an Immune Booster against COVID-19 Pandemic
Kumar, A., Singh, R. P., Kumar, I., Yadav, P., Singh, S. K., Kaushalendra, K., Singh, P. K., Gupta, R. K., Singh, S. M., Kesawat, M. S., et al. (2022) · Antioxidants · doi:10.3390/antiox11030452 · Cited by 21
Graikini, D., Soro, A. B., Saravana, P. S., Tiwari, B. K., & Sánchez, L. (2023) · Marine Drugs · doi:10.3390/md21090478 · Cited by 18
The Antiviral Potential of Algal Lectins
Alvarez, C., Félix, C., & Lemos, M. F. L. (2023) · Marine Drugs · doi:10.3390/md21100515 · Cited by 21
Preformulation Characterization of Griffithsin, a Biopharmaceutical Candidate for HIV Prevention
Kramzer, L. F., Hamorsky, K. T., Graebing, P. W., Wang, L., Fuqua, J. L., Matoba, N., Lasnik, A. B., Moncla, B. J., Zhang, J., Palmer, K. E., et al. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-01931-0 · Cited by 17
An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo
Zhao, Y., Zhao, N., Cai, Y., Zhang, H., Li, J., Liu, J., Ye, C., Wang, Y., Dang, Y., Li, W., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.881083 · Cited by 17
Detection, prevention and treatment of COVID‐19 and opportunities for nanobiotechnology
Bao, Q., Yang, T., Yang, M., & Mao, C. (2022) · View · doi:10.1002/viw.20200181 · Cited by 16
HIV-1 Entry and Prospects for Protecting against Infection
Bruxelle, J.-F., Trattnig, N., Mureithi, M., Landais, E., & Pantophlet, R. A. (2021) · Microorganisms · doi:10.3390/microorganisms9020228 · Cited by 19
The application and prospects of antimicrobial peptides in antiviral therapy
Yang, F., & Ma, Y. (2024) · Amino Acids · doi:10.1007/s00726-024-03427-0 · Cited by 18
Arumugam, G. S., Damodharan, K., Doble, M., & Thennarasu, S. (2022) · Molecular Biomedicine · doi:10.1186/s43556-022-00078-z · Cited by 15
Two Resveratrol Oligomers Inhibit Cathepsin L Activity to Suppress SARS-CoV-2 Entry
Wang, C., Ye, X., Ding, C., Zhou, M., Li, W., Wang, Y., You, Q., Zong, S., Peng, Q., Duanmu, D., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c07811 · Cited by 11
Porcine deltacoronavirus infection is inhibited by Griffithsin in cell culture
Tang, R., Guo, L., Fan, Q., Zhang, L., Wang, Y., Zhang, X., Shi, D., Wu, Y., Shi, H., Liu, J., et al. (2021) · Veterinary Microbiology · doi:10.1016/j.vetmic.2021.109299 · Cited by 10
Immune response and possible therapeutics in COVID-19
Dutta, A., Roy, A., Roy, L., Chattopadhyay, S., & Chatterjee, S. (2021) · RSC Advances · doi:10.1039/d0ra08901j · Cited by 10
How Can Plant-Derived Natural Products and Plant Biotechnology Help Against Emerging Viruses?
Zahmanova, G., Takova, K. H., Tonova, V., Minkov, I. N., Barbolov, M., Nedeva, N., Vankova, D. G., Ivanova, D. G., Kiselova-Kaneva, Y. D., & Lukov, G. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157046 · Cited by 9
Therapeutic potential and applications of red algae: a comprehensive scientific review
Balkrishna, A., Agarwal, U., Shrivastava, S., Chaudhary, S., & Arya, V. (2025) · Phytochemistry Reviews · doi:10.1007/s11101-025-10148-z · Cited by 13
Antunes, E. M., Beukes, D. R., Caro‐Diaz, E. J. E., Narchi, N. E., Tan, L. T., & Gerwick, W. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95227-9.00009-9 · Cited by 8
Tilapia lake virus: understanding incidence, enhancing resistance, and exploring seaweed therapies
Debbarma, S., Yadav, N. K., Devi, N. C., Bagthasingh, C., Yirang, Y., Meena, D. K., Singh, S. K., Mehta, N. K., & Mocherla, B. P. (2024) · Aquaculture International · doi:10.1007/s10499-024-01663-5 · Cited by 9
Wiggins, J., Karim, S.-U., Liu, B., Li, X., Zhou, Y., Bai, F., Yu, J., & Xiang, S.-H. (2024) · Viruses · doi:10.3390/v16101546 · Cited by 8
Prudêncio, R. D. S., de Sousa, A. K., Silva, D. M. M., Ferreira, J. D. S., Rocha, D. M. L., de Almeida, V. P. A., Sousa, J. J. D. S., Sousa, S. G., da Silva, T. M. L., Carvalho, A. D. S., et al. (2024) · Carbohydrate Research · doi:10.1016/j.carres.2024.109322 · Cited by 8
Heindel, D. W., Figueroa, D. M., Goff, M., Yengo, C. K., Jan, M., Liu, X., Wang, X., Petrova, M., Zhang, M., Sagar, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110390 · Cited by 8
Marine metabolites: oceans of opportunity
Facey, P. C., & Gallimore, W. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18657-8.00027-x · Cited by 10
Celis, I. C. S., & Matoba, N. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.105901 · Cited by 7
White, M. R., Nikolaidis, N. M., McCormack, F. X., Crouch, E. C., & Hartshorn, K. L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.774711 · Cited by 7
Al-Khayri, J. M., Asghar, W., Khan, S., Akhtar, A., Ayub, H., Khalid, N., Alessa, F. M., Al-Mssallem, M. Q., Adel Abdel-Sabour, R. E. Z. K., & Shehata, W. F. (2022) · Marine Drugs · doi:10.3390/md20080477 · Cited by 12
Research progress in the technology of active substance extraction from red algae
Qu, J., Liu, R., Yu, W., Li, W.-J., Lu, C., & Qin, S. (2025) · Algal Research · doi:10.1016/j.algal.2025.104244 · Cited by 6
Lectins in oncology and virology: Mechanisms of anticancer activity and SARS-CoV-2 inhibition
Boliukh, I., Rombel‐Bryzek, A., & Bułdak, R. J. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133664 · Cited by 6
Sharma, A. K., Virmani, T., Kumar, G., Singh, H., Mishra, A. K., Bhunia, A., Mohanto, S., Faiyazuddin, M., & Gugulothu, D. B. (2025) · Applied Food Research · doi:10.1016/j.afres.2025.101413 · Cited by 6
Antiviral potentials of marine algal bioactive compounds for coronavirus drug discovery
Kaparapu, J., Prasad, M. K., & Rao, G. M. N. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95574-4.00002-0 · Cited by 6
Antiviral Peptides Derived from Plants: Their Designs and Functions
Feyzyab, H., Fathi, N., & Bolhassani, A. (2023) · Protein and Peptide Letters · doi:10.2174/0109298665278148231106052509 · Cited by 5
Milk Oligosaccharides and Lectins as Candidates for Clinical Trials against Covid-19
Errasfa, M. (2020) · Current Nutrition & Food Science · doi:10.2174/1573401316999200819125355 · Cited by 5
Boger, M. F., Benhach, N., Hasselrot, T., Brand, R. M., Rohan, L. C., Wang, L., McGowan, I., Edick, S., Ho, K. S., Meyn, L. A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-34107-w · Cited by 7
Kandeel, M. K. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2192921 · Cited by 5
Algal Lectin Griffithsin Inhibits Ebola Virus Infection
Wang, L. L., Alfson, K. J., Eaton, B., Mattix, M. E., Goez-Gazi, Y., Holbrook, M. R., Carrion, R., & Xiang, S.-H. (2025) · Molecules · doi:10.3390/molecules30040892 · Cited by 4
Bridging Viral Glycobiology and Lectin Biotechnology for Antiviral and Diagnostic Strategies
Cavada, B. S., Osterne, V. J. S., Oliveira, M. V., Ferreira, W. P., Neto, C. C., Nascimento, K. S., & Pinto‐Junior, V. R. (2025) · ACS Bio & Med Chem Au · doi:10.1021/acsbiomedchemau.5c00115 · Cited by 7
A Genetically Engineered Biofilm Material for SARS‐CoV‐2 Capturing and Isolation
Özkul, G., Kehribar, E. Ş., Ahan, R. E., Köksaldı, İ. Ç., Özkul, A., Dinç, B., Aydoğan, S., & Şeker, U. Ö. Ş. (2022) · Advanced Materials Interfaces · doi:10.1002/admi.202201126 · Cited by 4
Algae natural products for potential vector-borne disease management
Assunção, J., Amaro, H. M., & Guedes, A. C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91942-5.00007-0 · Cited by 4
Bains, A., Fischer, K., Guan, W., & LiWang, P. J. (2023) · Viruses · doi:10.3390/v15122452 · Cited by 10
Shukla, A., Mongal, D., Mukherjee, G., & Sil, A. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823960-5.00019-6 · Cited by 4
Natural products and derivatives as Japanese encephalitis virus antivirals
Mi, Y., Guo, Y., Luo, X., Bai, Y., Chen, H., Wang, M., Wang, Y., & Guo, J. (2024) · Pathogens and Disease · doi:10.1093/femspd/ftae022 · Cited by 5
Maliki, I. M., Misson, M., Teoh, P. L., Rodrigues, K. F., Koh, W. Y., & Yong, W. T. L. (2024) · Phycological Research · doi:10.1111/pre.12570 · Cited by 3
Su, W., Liang, Y., Chen, Y., & Zhang, G. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.111282 · Cited by 3
Algal metabolites as emerging anti-virulence therapeutics against Pseudomonas aeruginosa
Chakraborty, A., Bhattacharya, D., Pandit, S., Gill, H. S., Rajeev, M., Lahiri, D., & Nag, M. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04614-7 · Cited by 3
From exploring cancer and virus targets to discovering active peptides through mRNA display
Brango‐Vanegas, J., Leite, M. L., de Oliveira, K. B. S., da Cunha, N. B., & Franco, O. L. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108559 · Cited by 3
Exploring the Structural Diversity and Biotechnological Potential of the Rhodophyte Phycolectome
Rodrigues, É. F., Verza, F. A., Nishimura, F. G., Beleboni, R. O., Hermans, C., Janssens, K., Mol, M. L. D., Hulpiau, P., & Marins, M. (2024) · Marine Drugs · doi:10.3390/md23010008 · Cited by 3
A bibliometric analysis of m6A methylation in viral infection from 2000 to 2022
Tao, X., Wang, G., Wei, W., Su, J., Xiu, C., Shi, M., Liao, Y., Qin, T., Wu, Y., Lü, B., et al. (2024) · Virology Journal · doi:10.1186/s12985-024-02294-1 · Cited by 3
A review of current research in the field of chemistry and pharmacology of algae
Mitishev, A. V., Vodop'yanova, O. A., Kurdyukov, E. E., Semenova, E. F., & Fednina, A. S. (2023) · Proceedings of universities Applied chemistry and biotechnology · doi:10.21285/2227-2925-2023-13-2-184-196 · Cited by 2
Natural Compounds for Inhibiting Oncogenic Microbiota: A Review of Their Therapeutic Applications
Velez-Haro, J. M., Velazquéz‐Marquez, S., & Velázquez-Márquez, N. (2024) · Springer eBooks · doi:10.1007/978-3-031-62558-9_18 · Cited by 2
Peptides Unplugged: Small Chains Tackling Big Challenges—One Life-Saving Sequence at a Time!
Bagwe, P. V., Sawant, S. S., & Joshi, S. V. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10729-8 · Cited by 2
Cyanobacteria and microalgae as promising sources of novel bioactive compounds: A review
Singh, S., Dwivedi, S., Shukla, M. K., Verma, A. K., Siddique, G. A., & Singh, D. K. (2025) · Journal of Advances in Microbiology Research · doi:10.22271/micro.2025.v6.i2c.263 · Cited by 3
Advances in rice synthetic biology: Toward a better staple crop and beyond
Zhang, C., Wang, Y., Chen, L., Wang, X., & Teng, S. (2025) · Journal of Integrative Agriculture · doi:10.1016/j.jia.2025.12.036 · Cited by 2
Metadata
- Authors
- Lee, C.
- Affiliations
- College of Pharmacy, Dongguk University, Goyang 10326, Korea
- ORCID
- Lee, Choongho
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2019-10-06
- Volume
- 17
- Issue
- 10
- Pages
- 567
- ISSN
- 1660-3397 (ISSN-L)
- PMC
- PMC6835697
- OpenAlex
- W2979023383
- Cited by
- 138
- References
- 64
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 20 · 2023: 21 · 2022: 29 · 2021: 24 · 2020: 19
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Marine Drugs (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (NRF) (NRF-2019R1F1A1058628)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- griffithsin, antiviral lectin, red algae, carbohydrate-binding proteins, viral entry inhibition, HIV, microbicides, host toxicity, pharmacokinetics, drug resistance, combination antiviral therapy, drug delivery, clinical trials
- MeSH terms
- Rhodophyta, Amino Acid Sequence, Animals, Antiviral Agents, Humans, HIV-1, HIV Infections, Plant Lectins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.